GLSI
#3361
Greenwich LifeSciences, Inc. - Common stock
17.7 7 USD
+0.08%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+7.50%
Variación mensual
+17.29%
Variación en los últimos 6 meses
-35.36%
Cambio anual
+74.22%
Cierres anteriores
16.5 3
Open
16.4 2
Mínimo
16.4 2
Máximo
17.9 7
Financials
- Market Capitalization 260.83 M
- Employee 13
- Founded 2006
- CEO N/A
- Website www.greenwichlifesciences.com
- Headquarter Delaware, United States
- FIGI BBG00V6PT8C7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3356 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 2.53 USD | -5.24% | -12.15% | -34.11% | -39.33% | 262.82 M USD | ||
| 3358 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 3.26 USD | -1.51% | -9.44% | -33.60% | -71.53% | 261.37 M USD | ||
| 3362 |  IPSC Century Therapeutics, Inc. - Common Stock | 1.44 USD | -2.04% | -2.70% | -26.53% | +161.82% | 260.75 M USD | ||
| 3370 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 1.85 USD | -6.09% | -7.50% | -20.94% | +17.09% | 258.14 M USD |